Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 149

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 149
---
    ●
    Roger J. Waltzman, M.D.,
    Chief Medical Officer

80

Summary
Compensation Table

The
following table sets forth all of the compensation awarded to, earned by or paid to our named executive officers during 2024 and 2023.

    Name and Principal Position 
    Year 
    Salary ($)  
    Bonus ($)  
    Stock Awards ($)  
    Option Awards(1) ($)  
    Non-equity Incentive Plan Compensation  
    All Other Compensation(2) ($)  
    Total ($) 
  
    Jeffrey A. Meckler, 
    2024 
     575,000  
     —  
     —  
     219,421  
     287,500  
     75,296  
     1,157,217 
  
    Chief Executive Office 
    2023 
     565,000  
     —  
     —  
     134,221  
     223,175  
     78,853  
     1,001,249 
  
    Walt A. Linscott, Esq., 
    2024 
     475,000  
     —  
     —  
     182,156  
     237,500  
     75,744  
     970,400 
  
    Chief Operating Officer 
    2023 
     425,000  
     —  
     —  
     53,688  
     212,500  
     78,851  
     770,039 
  
    Roger Waltzman, M.D. 
    2024 
     500,000  
     —  
     —  
     182,156  
     200,000  
     46,723  
     928,879 
  
    Chief Medical Officer 
    2023 
     196,742  
     20,000(3) 
     —  
     140,811  
     196,000  
     32,612  
     586,165 

(1)
The amounts reported do not reflect the amounts actually received by our named executive officers. Instead, in accordance with SEC rules,
these amounts reflect the grant date fair value of stock options granted to our named